Evaluation of Efficacy and Safety of Takmeed e Muhallil (Hot and Dry Fomentation with the Bundle of Specific Drugs) with Habb e Suranjan Orally in the Management of Plantar Fasciitis (Waja al Aqib)

Takmeed e Muhallil Hot and Dry Fomentation with the Bundle of Specific Drugs with Habb e Suranjan Orally in the Management of Plantar Fasciitis Waja al Aqib is designed to assess the safety and effectiveness of these Unani treatments in patients with plantar fasciitis. The aims are to provide a safe effective and economical treatment for heel pain and to improve the quality of life of patients. The study will be conducted at Hakim Syed Ziaul Hasan Government Autonomous Unani Medical College and Hospital Bhopal over a duration of one year with therapy lasting thirty five days. Plantar fasciitis is a common cause of heel pain disability and poor quality of life particularly in middle aged women obese individuals and young male athletes. In Unani medicine it is described as Waja al Aqib a type of Waja ul Mafasil or joint pain. Traditional remedies such as Takmeed and Habb e Suranjan have been used for pain and inflammation but require scientific validation. This randomized open controlled study will recruit eligible patients after ethical clearance and informed consent. Pre treatment investigations including blood tests arthritis profile X ray and ultrasound of the foot will be done. The test group will receive Takmeed e Muhallil locally along with Habb e Suranjan orally while the control group will receive therapeutic ultrasound. Treatment will be given in multiple sittings over four weeks and patients will be followed up on days 7 14 21 28 and 35. Outcomes will be measured using Visual Analogue Scale Lower Extremity Functional Scale SF 12 quality of life and range of motion by goniometer. The inclusion criteria are patients aged 18 to 60 years with plantar fasciitis with or without calcaneal spur and without surgical indication or malignancy. Exclusion criteria include rheumatoid arthritis osteoporosis systemic arthritis infections vascular or metabolic diseases such as gout pregnancy and recent steroid or NSAID use. The total sample size will be 44 patients with 22 in each group. Temperament or Mizaj will also be assessed according to classical Unani parameters. Concomitant medications will be recorded but painkillers will only be permitted in urgent situations as rescue therapy.